Biologics and Biosimilars as Treatment Options for Psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
第一著者: | Moya, Amena Khatun |
---|---|
その他の著者: | Kabir, Dr. Eva Rahman |
フォーマット: | 学位論文 |
言語: | en_US |
出版事項: |
Brac University
2023
|
主題: | |
オンライン・アクセス: | http://hdl.handle.net/10361/17712 |
類似資料
-
Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
著者:: Akter, Anika
出版事項: (2022) -
A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
著者:: Islam, Nahidul
出版事項: (2023) -
Detection of skin diseases using deep learning
著者:: Shodoy, Masuk Ur Rahman
出版事項: (2024) -
Biosimilar in lymphoma treatment
著者:: Tanisha, Mehrin Haque
出版事項: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
著者:: Tabassum, Turana
出版事項: (2022)